0001209191-21-038457.txt : 20210604 0001209191-21-038457.hdr.sgml : 20210604 20210604200948 ACCESSION NUMBER: 0001209191-21-038457 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210603 FILED AS OF DATE: 20210604 DATE AS OF CHANGE: 20210604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reasons Bryan M. CENTRAL INDEX KEY: 0001553489 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37581 FILM NUMBER: 21997966 MAIL ADDRESS: STREET 1: C/O IMPAX LABORATORIES, INC. STREET 2: 30831 HUNTWOOD AVENUE CITY: HAYWARD STATE: CA ZIP: 94544 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001557746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460571712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 640 LEE ROAD STREET 2: SUITE 200 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 484-324-7933 MAIL ADDRESS: STREET 1: 640 LEE ROAD STREET 2: SUITE 200 CITY: WAYNE STATE: PA ZIP: 19087 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-03 0 0001557746 Aclaris Therapeutics, Inc. ACRS 0001553489 Reasons Bryan M. C/O ACLARIS THERAPEUTICS, INC. 640 LEE ROAD, SUITE 200 WAYNE PA 19087 1 0 0 0 Stock Option (Right to Buy) 21.90 2021-06-03 4 A 0 12250 0.00 A 2031-06-02 Common Stock 12250 12250 D Restricted Stock Units 2021-06-03 4 A 0 3356 0.00 A Common Stock 3356 3356 D This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy. The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date. Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date. /s/ Mark Ballantyne, Attorney-in-Fact 2021-06-04